Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (151-160 of 208) with videos related to

Pageof 21
Sort By:
Scientific Reports|March 9, 2019
Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteriaMatteo Ravaioli, Federica Odaldi, Alessandro Cucchetti, et al.
International Journal of Antimicrobial Agents|June 11, 2023
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university hospital: Findings after the first year of implementationPier Giorgio Cojutti, Milo Gatti, Francesca Bonifazi, et al.
Journal of Clinical Medicine|December 23, 2022
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added ValueCristina Mosconi, Alberta Cappelli, Cinzia Pettinato, et al.
Cancers|April 30, 2021
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC ClassificationsAlessandro Vitale, Fabio Farinati, Michele Finotti, et al.
Annals of Surgical Oncology|December 10, 2024
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative AnalysisUmberto Cillo, Silvia Caregari, Matteo Barabino, et al.
The American Journal of Gastroenterology|January 6, 2016
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
The American Journal of Gastroenterology|June 19, 2018
Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2023
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part I - Surgical treatmentsGiuseppe Cabibbo, Bruno Daniele, Mauro Borzio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2018
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort StudyDavid J Pinato, Elias Allara, Ting-Yi Chen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 18, 2015
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictorAlessandro Vitale, Fabio Farinati, Patrizia Burra, et al.
Pageof 21

Showing results (151-160 of 208) with videos related to

Sort By:
Pageof 21
Scientific Reports|March 9, 2019
Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteriaMatteo Ravaioli, Federica Odaldi, Alessandro Cucchetti, et al.
International Journal of Antimicrobial Agents|June 11, 2023
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university hospital: Findings after the first year of implementationPier Giorgio Cojutti, Milo Gatti, Francesca Bonifazi, et al.
Journal of Clinical Medicine|December 23, 2022
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added ValueCristina Mosconi, Alberta Cappelli, Cinzia Pettinato, et al.
Cancers|April 30, 2021
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC ClassificationsAlessandro Vitale, Fabio Farinati, Michele Finotti, et al.
Annals of Surgical Oncology|December 10, 2024
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative AnalysisUmberto Cillo, Silvia Caregari, Matteo Barabino, et al.
The American Journal of Gastroenterology|January 6, 2016
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
The American Journal of Gastroenterology|June 19, 2018
Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular CarcinomaEdoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2023
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part I - Surgical treatmentsGiuseppe Cabibbo, Bruno Daniele, Mauro Borzio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2018
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort StudyDavid J Pinato, Elias Allara, Ting-Yi Chen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 18, 2015
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictorAlessandro Vitale, Fabio Farinati, Patrizia Burra, et al.
Pageof 21